Home › Funds › waypoint wealth counsel › REGN
waypoint wealth counsel position in REGN
REGENERON PHARMACEUTICALS · Health Care
waypoint wealth counsel reported holding 805 shares of REGN (REGENERON PHARMACEUTICALS) in its Q3 2026 13F filing — a position valued at US$610K, representing 0.38% of its reported portfolio and ranking #44 among its reported holdings. waypoint wealth counsel has disclosed REGN holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How waypoint wealth counsel's REGN position evolved
waypoint wealth counsel first disclosed a stake in REGN in Q3 2025 at 976 shares (US$549K). The position peaked in Q1 2026 at 1,085 shares, worth US$838K. Across 5 filings, waypoint wealth counsel increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 805 shares valued at US$610K — an increase of 28 shares quarter over quarter.. Notable position changes include a 28% trim in Q2 2026 (shares rose 22% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 976 | $548.78K | New |
| Q4 2025 | 1.08K | $835.16K | Add |
| Q1 2026 | 1.08K | $838.32K | Hold |
| Q2 2026 | 777 | $484.49K | Reduce |
| Q3 2026 | 805 | $610.41K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About REGN and 13F data
REGN (REGENERON PHARMACEUTICALS) is a Health Care company. 29 other funds we track also report a position in REGN — the largest reported positions include Dodge & Cox (US$3.04B), DODGE & COX (US$3.04B), Franklin Resources (US$2.75B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding REGN
- Dodge & Cox 4.87M sh · $3.04B · Q2 2026
- DODGE & COX 4.87M sh · $3.04B · Q2 2026
- Franklin Resources 2.95M sh · $2.75B · Q3 2026
- Nuveen, LLC 1.96M sh · $1.48B · Q3 2026
- LOOMIS SAYLES & CO L P 1.72M sh · $1.30B · Q3 2026
More on waypoint wealth counsel
FAQ
How long has waypoint wealth counsel held REGN?
waypoint wealth counsel has disclosed REGN holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
What is waypoint wealth counsel's current position in REGN?
As of Q3 2026, waypoint wealth counsel holds 805 shares of REGN (REGENERON PHARMACEUTICALS), valued at $610.41K, representing 0.38% of its reported portfolio and ranking #44.
Has waypoint wealth counsel been buying or selling REGN?
In the latest 13F filing (Q3 2026), waypoint wealth counsel increased its position in REGN. The position peaked in Q1 2026 at 1.08K shares.
Which other funds hold REGN?
Other major institutional holders of REGN include Dodge & Cox, DODGE & COX, Franklin Resources, among 29 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.